SEC EDGAR CompanyFacts fact · reporting period
ARBUTUS BIOPHARMA CORP: capex
One fact, its scope and the complete path back to the official record.
Reported value
$725.000k{"amount": 725000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}- Entity
- ARBUTUS BIOPHARMA CORP
- Metric
- capex
- Period
- 2013-01-01 – 2013-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:17:30.931798+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001447028/capex/2013-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 725100, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001171843-14-001132)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.